In the present study, we explore the innovative and rational combination of TCS with benserazide hydrochloride (Benz), a HK2 inhibitor, using HeLa (human cervical cancer) and SCC25 (human oral squamous cell carcinoma) cells as cancer models. Here, HK2 is linked to cervical carcinoma.